CannTrust Holdings Inc. (TSX :TRST ) announced this morning that the company has completed its first international shipment of cannabis oils based products to STENOCARE, a Danish company focused on the sale of CBD and THC based medicinal goods.
CannTrust and STENOCARE have formed a joint venture partnership to offer consumers in Denmark cannabis oils for medicinal purposes. By doing so that partners are the first t cannabinoid-based product to be accepted by the Danish Medicine Agency. CannaTrust has imported CBD, THC, and a 1:1 ratio of CBD to THC tinctures into the country.
Though recreationally illegal in Denmark, the consumption of cannabis products are allowed for medicinal use with a prescription. Over the past few years the country has gained some political support for the use of the plant for a variety of different ailments which lead to the legalization of medical cannabis in 2018.
Companies like CannTrust Holding look to capitalize on what is now a growing demand for a variety of different cannabinoid derived products by the citizens of Denmark.
By partnering with STENOCARE, CannTrust is assured distribution of their products through their network of pharmacies and hospitals, as well as, a trusted partner located in the region that has gained approval to cultivate of cannabis varieties by from the Danish Medicines Agency.
Brad Rogers, President of CannTrust Holdings gave this statement in the press release:
“This first shipment of CannTrust products to STENOCARE marks an important advancement of medical cannabis in Denmark and is just the beginning of many shared successes for our two companies. It also signals a significant step in CannTrust’s international expansion.”